Search

Your search keyword '"Nakanishi, Yoichi"' showing total 747 results

Search Constraints

Start Over You searched for: Author "Nakanishi, Yoichi" Remove constraint Author: "Nakanishi, Yoichi" Search Limiters Full Text Remove constraint Search Limiters: Full Text
747 results on '"Nakanishi, Yoichi"'

Search Results

2. A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

3. Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC

8. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry

9. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L

15. Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis

21. Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial

22. Additional file 1 of A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

23. Additional file 2 of A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

32. An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion

33. Pulse oximetry is an essential tool that saves lives: a call for standardisation

34. Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer

35. Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset

50. Biochemical, Structural and Physiological Characteristics of Vacuolar H^+-Pyrophosphatase

Catalog

Books, media, physical & digital resources